Publications by authors named "Pierre-Marie Girard"


[Diseases of repair].

Bull Cancer 2021 Jan 7. Epub 2021 Jan 7.

Université PSL, université Paris-Saclay, Institut Curie, Centre de Recherche, CNRS UMR3347, Inserm U1021, Orsay, France. Electronic address:

View Article and Find Full Text PDF
January 2021

Pharmacological data of a successful 4-days-a-week regimen in HIV antiretroviral therapy (ANRS 162-4D trial).

Br J Clin Pharmacol 2020 Oct 3. Epub 2020 Oct 3.

Département de Pharmacologie-Toxicologie, Hôpitaux Universitaires Paris-Ile de France-Ouest, APHP, Hôpital Raymond Poincaré, MasSpecLab, Plateforme de spectrométrie de masse, Inserm U-1173, Université Versailles Saint Quentin-en-Yvelines, Garches, France.

View Article and Find Full Text PDF
October 2020

Ritonavir associated maculopathy- multimodal imaging and electrophysiology findings.

Am J Ophthalmol Case Rep 2020 Sep 22;19:100783. Epub 2020 Jul 22.

Department of Ophthalmology, Centre Hospitalier Intercommunal de Creteil University Paris Est Creteil, 40 Avenue de Verdun, 94000, Creteil, France.

View Article and Find Full Text PDF
September 2020

Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 Infection.

N Engl J Med 2020 03 4;382(12):1124-1135. Epub 2020 Mar 4.

From Queen Mary University of London, London (C.O.), and ViiV Healthcare, Brentford (V.C.) - both in the United Kingdom; EPIMED, Berlin (K.A.); Fundación Jiménez Díaz, Madrid (M.G.H.-M.); Central Research Institute of Epidemiology, Moscow (V.P.); the University of Alabama at Birmingham, Birmingham (E.T.O.); Hôpital Saint Antoine, Paris (P.-M.G.), and Hôpital Européen, Marseille (P. Philibert) - both in France; the National Center for Global Health and Medicine, Tokyo (S.O.); the University Health Network, University of Toronto, Toronto (S.W.), and GlaxoSmithKline, Mississauga (S.L.F., D.D.) - both in Ontario, Canada; North Texas Infectious Disease Consultants, Dallas (C. Bettacchi), and Central Texas Clinical Research, Austin (C. Brinson); Josha Research, Bloemfontein, South Africa (J.L.); ViiV Healthcare, Research Triangle Park, NC (M.S.C., P. Patel, R.D., A.C., S.G., D.A.M., K.Y.S., W.R.S.); and Janssen Research and Development, Beerse, Belgium (H.C., S.V., P.E.W., W.P.).

View Article and Find Full Text PDF
March 2020

AsiDNA Treatment Induces Cumulative Antitumor Efficacy with a Low Probability of Acquired Resistance.

Neoplasia 2019 09 27;21(9):863-871. Epub 2019 Jul 27.

Institut Curie, PSL Research University, CNRS, INSERM, UMR 3347, F-91405, Orsay, France; Université Paris-Sud, Université Paris-Saclay, CNRS, INSERM, UMR 3347, F-91405 Orsay, France. Electronic address:

View Article and Find Full Text PDF
September 2019